Etanercept prevents airway hyperresponsiveness by protecting neuronal M 2 muscarinic receptors in antigen-challenged guinea pigs

British Journal of Pharmacology

Volumn 156, Issue 1, 2009, Pages 201-210

  Nie, Zhenying ^a   Jacoby, David B ^a   Fryer, Allison D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Airway hyperreactivity; Asthma; Eosinophil; TNF

Indexed keywords

ACETYLCHOLINE; ETANERCEPT; MAJOR BASIC PROTEIN; MUSCARINIC M2 RECEPTOR; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRONCHOSPASM; CONTROLLED STUDY; EOSINOPHIL; GUINEA PIG; HEART RATE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PRESSURE; NEUROBLASTOMA CELL; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; PROVOCATION TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VAGUS NERVE STIMULATION; ANIMAL; BIOSYNTHESIS; BRONCHUS HYPERREACTIVITY; CHOLINERGIC SYSTEM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HEART MUSCLE; IMMUNOLOGY; INNERVATION; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE; TRACHEA; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; CELL LINE, TUMOR; EOSINOPHILS; GUINEA PIGS; HUMANS; IMMUNOGLOBULIN G; MUSCLE, SMOOTH; MYOCARDIUM; NEURONS; OVALBUMIN; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTOR, MUSCARINIC M2; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549128183     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00045.x     Document Type: Article

References (56)

1. Adamko DJ, Yost BL, Gleich GJ, Fryer AD, Jacoby DB (1999). Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J Exp Med 190 : 1465 1478.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
3. Arbach O, Gross WL, Gause A (2002). Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade. Immunobiology 206 : 496 501.
4. Ayala LE, Ahmed T (1989). Is there loss of protective muscarinic receptor mechanism in asthma? Chest 96 : 1285 1291.
5. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK (1992). T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 145 : 1477 1482.
6. Baker DG, Don HF, Brown JK (1992). Direct measurement of acetylcholine release in guinea pig trachea. Am J Physiol 263 : L142 L147.
7. Bernardini N, Roza C, Sauer SK, Gomeza J, Wess J, Reeh PW (2002). Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception. J Neurosci 22 : RC229.
8. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH et al. (2006). Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 354 : 697 708.
9. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R et al. (1994). Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10 : 471 480.
10. Bravo Vergel Y, Hawkins NS, Claxton K, Asseburg C, Palmer S, Woolacott N et al. (2007). The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford) 46 : 1729 1735.
11. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI (1992). Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 89 : 958 967.
12. Careau E, Proulx LI, Pouliot P, Spahr A, Turmel V, Bissonnette EY (2006). Antigen sensitization modulates alveolar macrophage functions in an asthma model. Am J Physiol Lung Cell Mol Physiol 290 : L871 L879.
13. Cazzola M, Polosa R, Erzurum SC, Berry MA, Hargadon B, Shelley M et al. (2006). Anti-TNF-alpha and Th2 cytokine directed therapies for the treatment of asthma. Curr Opin Allergy Clin Immunol 6 : 43 50.
14. Chanez P, Wenzel SE, Anderson GP, Anto JM, Bel EH, Boulet LP et al. (2007). Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 119 : 1337 1348.
15. Choi IW, Sun K, Kim YS, Ko HM, Im SY, Kim JH et al. (2005). TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cyto/ic phospholipase A(2) activation. J Allergy Clin Immunol 116 : 537 543.
16. Costello RW, Schofield BH, Kephart GM, Gleich GJ, Jacoby DB, Fryer AD (1997). Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol 273 : L93 L103.
17. Coulson FR, Jacoby DB, Fryer AD (2004). Insulin regulates neuronal M2 muscarinic receptor function in the ileum of diabetic rats. J Pharmacol Exp Ther 308 : 760 766.
18. Elbon CL, Jacoby DB, Fryer AD (1995). Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs. Am J Respir Cell Mol Biol 12 : 320 328.
19. Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, Neighbour H et al. (2006). The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 174 : 753 762.
20. Evans CM, Fryer AD, Jacoby DB, Gleich GJ, Costello RW (1997). Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 100 : 2254 2262.
21. Fryer AD, Jacoby DB (1992). Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J Clin Invest 90 : 2292 2298.
22. Fryer AD, Maclagan J (1984). Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 83 : 973 978.
23. Fryer AD, Wills-Karp M (1991). Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge. J Appl Physiol 71 : 2255 2261.
24. Fryer AD, Costello RW, Yost BL, Lobb RR, Tedder TF, Steeber DA et al. (1997). Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways. J Clin Invest 99 : 2036 2044.
25. Fryer AD, Stein LH, Nie Z, Curtis DE, Evans CM, Hodgson ST et al. (2006). Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest 116 : 228 236.
26. Ghaffar O, Hamid Q, Renzi PM, Allakhverdi Z, Molet S, Hogg JC et al. (1999). Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 159 : 1933 1942.
27. Gosset P, Tsicopoulos A, Wallaert B, Vannimenus C, Joseph M, Tonnel AB et al. (1991). Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 88 : 561 571.
28. Grau GE, Roux-Lombard P, Gysler C, Lambert C, Lambert PH, Dayer JM et al. (1989). Serum cytokine changes in systemic vasculitis. Immunology 68 : 196 198.
29. Haddad EB, Rousell J, Lindsay MA, Barnes PJ (1996). Synergy between tumor necrosis factor alpha and interleukin 1beta in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression. Involvement of protein kinase A and ceramide pathways. J Biol Chem 271 : 32586 32592.
30. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N et al. (2001). A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2 : 353 360.
31. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W et al. (2005). Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60 : 1012 1018.
32. Hutchison S, Choo-Kang BS, Bundick RV, Leishman AJ, Brewer JM, McInnes IB et al. (2008). Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation. Clin Exp Immunol 151 : 114 122.
33. Jacoby DB, Gleich GJ, Fryer AD (1993). Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest 91 : 1314 1318.
34. Kakurai M, Monteforte R, Suto H, Tsai M, Nakae S, Galli SJ (2006). Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol 169 : 1713 1721.
35. Keith RG, Keshavjee SH, Kerenyi NR (1985). Neuropathology of chronic pancreatitis in humans. Can J Surg 28 : 207 211.
36. Kim J, McKinley L, Natarajan S, Bolgos GL, Siddiqui J, Copeland S et al. (2006). Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust. Clin Exp Allergy 36 : 122 132.
37. Kim YS, Ko HM, Kang NI, Song CH, Zhang X, Chung WC et al. (2007). Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-alpha in a murine model of asthma. Eur J Immunol 37 : 1107 1115.
38. Kivilcim M, Peyman GA, Kazi AA, Dellacroce J, Ghobrial RN, Monzano R (2007). Intravitreal toxicity of high-dose etanercept. J Ocul Pharmacol Ther 23 : 57 62.
39. Lesslauer W, Tabuchi H, Gentz R, Brockhaus M, Schlaeger EJ, Grau G et al. (1991). Recombinant /uble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 21 : 2883 2886.
40. Love JA (2000). Electrical properties and synaptic potentials of rabbit pancreatic neurons. Auton Neurosci 84 : 68 77.
41. Minette PA, Lammers JW, Dixon CM, McCusker MT, Barnes PJ (1989). A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 67 : 2461 2465.
42. Nakae S, Ho LH, Yu M, Monteforte R, Iikura M, Suto H et al. (2007). Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 120 : 48 55.
43. Nie Z, Nelson CS, Jacoby DB, Fryer AD (2007). Expression and regulation of intercellular adhesion molecule-1 on airway parasympathetic nerves. J Allergy Clin Immunol 119 (6 1415 1422.
44. Ohashi Y, Motojima S, Fukuda T, Makino S (1992). Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 145 : 1469 1476.
45. Peppel K, Crawford D, Beutler B (1991). A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174 : 1483 1489.
46. Proskocil BJ, Bruun DA, Lorton JK, Blensly KC, Jacoby DB, Lein PJ et al. (2008). Antigen sensitization influences organophosphorus pesticide-induced airway hyperreactivity. Environ Health Perspect 116 : 381 388.
47. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM (2003). Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111 : 821 831.
48. Rouhani FN, Meitin CA, Kaler M, Miskinis-Hilligoss D, Stylianou M, Levine SJ (2005). Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation. Respir Med 99 : 1175 1182.
49. Sawatzky DA, Kingham PJ, Court E, Kumaravel B, Fryer AD, Jacoby DB et al. (2002). Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation. Am J Physiol Lung Cell Mol Physiol 282 : L1279 L1288.
50. Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R (1995). Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 155 : 5038 5045.
51. Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A (2001). Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. J Rheumatol 28 : 1677 1680.
52. Thomas PS (2001). Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 79 : 132 140.
53. Tsukadaira A, Okubo Y, Kitano K, Horie S, Momose T, Takashi S et al. (1999). Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 20 : 39 44.
54. Verbout NG, Lorton JK, Jacoby DB, Fryer AD (2007). Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 292 : L1126 L1135.
55. Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM, Wolfe F (2008). Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis. Arthritis Rheum 58 : 939 946.
56. Zhang K, Gharaee-Kermani M, McGarry B, Remick D, Phan SH (1997). TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol 158 : 954 959.